Table 4 Comparison of our integrated analysis with similar studies reported in the literature.
Cancer type | Gene-expression | mRNA–miRNA–lncRNA–drugs | Hub identification | Functional module /subnetwork extraction | Pathway enrichment analysis | Oncoprint and survival analysis | Mutation circos plots | References |
|---|---|---|---|---|---|---|---|---|
Colon cancer | Yes | No | Yes | Yes | Yes | Yes | No | |
Oral cancer | Yes | No | Yes | Yes | Yes | Yes | No | |
Cervical cancer | Yes | No | Yes | Yes | Yes | Yes | No | |
Triple-negative breast cancer | Yes | No | Yes | Yes | Yes | Yes | No | |
Breast cancer | No | No | Yes | No | Yes | No | ||
benzo[a]pyrene-treated breast cancer cells | No | No | No | No | Yes | No | No | |
Gastric cancer | Yes | No | Yes | Yes | Yes | No | No | |
Hepatocellular carcinoma | Yes | No | Yes | Yes | Yes | No | No | |
Prostate cancer | No | No | No | Yes | Yes | No | No | |
Breast cancer | Yes | Yes | Yes | Yes | Yes | Yes | Yes | This study |
